Ninety One Uk LTD Boston Scientific Corp Transaction History

Ninety One Uk LTD

$36.1 Billion
Q3 2024

A detailed history of Ninety One Uk LTD transactions in Boston Scientific Corp stock. As of the latest transaction made, Ninety One Uk LTD holds 4,214,752 shares of BSX stock, worth $379 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares

4,214,752

Previous 4,313,087 2.28%

Holding current value

$379 Million

Previous $332 Million 6.34%

% of portfolio

0.98%

Previous 0.94%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$72.96 - $84.0 $7.17 Million - $8.26 Million	-98,335 Reduced 2.28%	4,214,752 $353 Million
Q2 2024 Jul 22, 2024	SELL	$67.33 - $77.71 $5.79 Million - $6.68 Million	-86,013 Reduced 1.96%	4,313,087 $332 Million
Q1 2024 Apr 25, 2024	SELL	$57.6 - $68.62 $2.86 Million - $3.41 Million	-49,676 Reduced 1.12%	4,399,100 $301 Million
Q4 2023 Jan 31, 2024	SELL	$48.64 - $57.81 $20 Million - $23.8 Million	-412,050 Reduced 8.48%	4,448,776 $257 Million
Q3 2023 Oct 10, 2023	SELL	$50.19 - $54.68 $8.55 Million - $9.32 Million	-170,404 Reduced 3.39%	4,860,826 $257 Million
Q2 2023 Jul 19, 2023	SELL	$49.72 - $54.64 $1.22 Million - $1.34 Million	-24,490 Reduced 0.48%	5,031,230 $272 Million
Q1 2023 Apr 28, 2023	SELL	$45.09 - $50.03 $31.7 Million - $35.2 Million	-703,327 Reduced 12.21%	5,055,720 $253 Million
Q4 2022 Feb 07, 2023	BUY	$39.56 - $47.22 $10.2 Million - $12.2 Million	258,813 Added 4.71%	5,759,047 $267 Million
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $26.7 Million - $79.7 Million	-726,848 Reduced 11.67%	5,500,234 $213 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $219 Million - $293 Million	6,227,082 New	6,227,082 $232 Million

Others Institutions Holding BSX

# of Institutions

1,539

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ninety One Uk LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ninety One Uk LTD with notifications on news.

Account